VEDI ANCHE...
IGF2BP Anticorpi
Empty Table Header | Nome del prodotto | CATALOG # | Isotipo | Epitopo | Applicazione | Species | CITAZIONI | Valutazione |
---|---|---|---|---|---|---|---|---|
IMP-1/IGF2BP1 Anticorpo (D-9) | sc-166344 | mouse IgM κ | 324-367 (h) | WB, IP, IF, IHC(P), ELISA | m, r, h | 13 | ||
IMP-1/IGF2BP1 Anticorpo (G-8) | sc-390149 | mouse IgG1 κ | (h) | WB, IP, IF, ELISA | m, r, h | 2 | ||
IGF2BP2 Anticorpo (F-12) | sc-377014 | mouse IgG1 κ | 367-436 (h) | WB, IP, IF, IHC(P), ELISA | h | 6 | ||
IGF2BP3 Anticorpo (DE-7) | sc-100766 | mouse IgM | 1-580 (h) | WB, IP, ELISA | m, r, h | new | ||
IGF2BP3 Anticorpo (E-2) | sc-365640 | mouse IgG2b κ | 149-180 (h) | WB, IP, IF, IHC(P), ELISA | h | 7 | ||
IGF2BP3 Anticorpo (C-11) | sc-365641 | mouse IgG1 κ | 149-180 (h) | WB, IP, IF, IHC(P), ELISA | h | 3 | ||
IGF2BP3 Anticorpo (G-9) | sc-376067 | mouse IgG2a κ | 149-180 (h) | WB, IP, IF, ELISA | h | new | ||
IGF2BP3 Anticorpo (D-7) | sc-390639 | mouse IgG1 κ | 377-413 (h) | WB, IP, IF, IHC(P), ELISA | m, r, h | 2 | ||
IGF2BP1/2/3 Anticorpo (A-2) | sc-271785 | mouse IgG1 κ | 278-577 (h) | WB, IP, IF, IHC(P), ELISA | m, r, h | 3 |
IGF2BP CRISPR Knockout, HDR and Double Nickase Plasmids
Empty Table Header | Nome del prodotto | CATALOG # | Species | Applicazione | MARCATORE | CITAZIONI | Valutazione |
---|---|---|---|---|---|---|---|
IMP-1/IGF2BP1 Plasmide KO CRISPR/Cas9 (h) | sc-401703 | h | Gene Knockout | GFP | 3 | ||
IMP-1/IGF2BP1 Plasmide HDR (h) | sc-401703-HDR | h | Homology Directed Repair | Puromycin | 3 | ||
IMP-1/IGF2BP1 Plasmide Double Nickase (h) | sc-401703-NIC | h | Gene Knockout | Puromycin | 3 | ||
IMP-1/IGF2BP1 Plasmide Double Nickase (h2) | sc-401703-NIC-2 | h | Gene Knockout | Puromycin | 3 | ||
IMP-1/IGF2BP1 Plasmide KO CRISPR/Cas9 (m) | sc-431212 | m | Gene Knockout | GFP | 0 | ||
IMP-1/IGF2BP1 Plasmide HDR (m) | sc-431212-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
IMP-1/IGF2BP1 Plasmide Double Nickase (m) | sc-431212-NIC | m | Gene Knockout | Puromycin | 0 | ||
IMP-1/IGF2BP1 Plasmide Double Nickase (m2) | sc-431212-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
IGF2BP2 Plasmide KO CRISPR/Cas9 (h) | sc-404985 | h | Gene Knockout | GFP | 0 | ||
IGF2BP2 Plasmide HDR (h) | sc-404985-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
IGF2BP2 Plasmide Double Nickase (h) | sc-404985-NIC | h | Gene Knockout | Puromycin | 0 | ||
IGF2BP2 Plasmide Double Nickase (h2) | sc-404985-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
IGF2BP2 Plasmide KO CRISPR/Cas9 (m) | sc-435664 | m | Gene Knockout | GFP | 0 | ||
IGF2BP2 Plasmide HDR (m) | sc-435664-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
IGF2BP2 Plasmide Double Nickase (m) | sc-435664-NIC | m | Gene Knockout | Puromycin | 0 | ||
IGF2BP2 Plasmide Double Nickase (m2) | sc-435664-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
IGF2BP3 Plasmide KO CRISPR/Cas9 (m) | sc-431213 | m | Gene Knockout | GFP | 0 | ||
IGF2BP3 Plasmide HDR (m) | sc-431213-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
IGF2BP3 Plasmide Double Nickase (m) | sc-431213-NIC | m | Gene Knockout | Puromycin | 0 | ||
IGF2BP3 Plasmide Double Nickase (m2) | sc-431213-NIC-2 | m | Gene Knockout | Puromycin | 0 |
IGF2BP CRISPR Activation Products
Empty Table Header | Nome del prodotto | CATALOG # | Species | Applicazione | MARCATORE | CITAZIONI | Valutazione |
---|---|---|---|---|---|---|---|
IMP-1/IGF2BP1 Plasmide di attivazione CRISPR (h) | sc-401703-ACT | h | Gene Activation | Puro, Blast, Hygro | 3 | ||
IMP-1/IGF2BP1 Plasmide di attivazione CRISPR (h2) | sc-401703-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 3 | ||
IMP-1/IGF2BP1 Particelle di Attivazione Lentivirale (h) | sc-401703-LAC | h | Gene Activation | Puro, Blast, Hygro | 3 | ||
IMP-1/IGF2BP1 Particelle di Attivazione Lentivirale (h2) | sc-401703-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 3 | ||
IMP-1/IGF2BP1 Plasmide di attivazione CRISPR (m) | sc-431212-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
IMP-1/IGF2BP1 Plasmide di attivazione CRISPR (m2) | sc-431212-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
IMP-1/IGF2BP1 Particelle di Attivazione Lentivirale (m) | sc-431212-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
IMP-1/IGF2BP1 Particelle di Attivazione Lentivirale (m2) | sc-431212-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
IGF2BP2 Plasmide di attivazione CRISPR (h) | sc-404985-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
IGF2BP2 Plasmide di attivazione CRISPR (h2) | sc-404985-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
IGF2BP2 Particelle di Attivazione Lentivirale (h) | sc-404985-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
IGF2BP2 Particelle di Attivazione Lentivirale (h2) | sc-404985-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
IGF2BP2 Plasmide di attivazione CRISPR (m) | sc-435664-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
IGF2BP2 Plasmide di attivazione CRISPR (m2) | sc-435664-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
IGF2BP2 Particelle di Attivazione Lentivirale (m) | sc-435664-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
IGF2BP2 Particelle di Attivazione Lentivirale (m2) | sc-435664-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
IGF2BP3 Plasmide di attivazione CRISPR (m) | sc-431213-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
IGF2BP3 Plasmide di attivazione CRISPR (m2) | sc-431213-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
IGF2BP3 Particelle di Attivazione Lentivirale (m) | sc-431213-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
IGF2BP3 Particelle di Attivazione Lentivirale (m2) | sc-431213-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 |
IGF2BP siRNA, shRNA Plasmid and shRNA Lentiviral Particle Gene Silencers
Empty Table Header | Nome del prodotto | CATALOG # | Species | Applicazione | MARCATORE | CITAZIONI | Valutazione |
---|---|---|---|---|---|---|---|
IMP-1/IGF2BP1 siRNA (h) | sc-40694 | h | Gene Silencing | N/A | 4 | ||
IMP-1/IGF2BP1 Plasmide shRNA (h) | sc-40694-SH | h | Gene Silencing | Puromycin | 4 | ||
IMP-1/IGF2BP1 shRNA (h) Particelle lentivirali | sc-40694-V | h | Gene Silencing | Puromycin | 4 | ||
IMP-1/IGF2BP1 siRNA (m) | sc-40695 | m | Gene Silencing | N/A | 1 | ||
IMP-1/IGF2BP1 Plasmide shRNA (m) | sc-40695-SH | m | Gene Silencing | Puromycin | 1 | ||
IMP-1/IGF2BP1 shRNA (m) Particelle lentivirali | sc-40695-V | m | Gene Silencing | Puromycin | 1 | ||
IMP-1/IGF2BP1 siRNA (r) | sc-270306 | r | Gene Silencing | N/A | 0 | ||
IMP-1/IGF2BP1 Plasmide shRNA (r) | sc-270306-SH | r | Gene Silencing | Puromycin | 0 | ||
IMP-1/IGF2BP1 shRNA (r) Particelle lentivirali | sc-270306-V | r | Gene Silencing | Puromycin | 0 | ||
IGF2BP2 siRNA (h) | sc-78065 | h | Gene Silencing | N/A | 1 | ||
IGF2BP2 Plasmide shRNA (h) | sc-78065-SH | h | Gene Silencing | Puromycin | 1 | ||
IGF2BP2 shRNA (h) Particelle lentivirali | sc-78065-V | h | Gene Silencing | Puromycin | 1 | ||
IGF2BP2 siRNA (m) | sc-146180 | m | Gene Silencing | N/A | 2 | ||
IGF2BP2 Plasmide shRNA (m) | sc-146180-SH | m | Gene Silencing | Puromycin | 2 | ||
IGF2BP2 shRNA (m) Particelle lentivirali | sc-146180-V | m | Gene Silencing | Puromycin | 2 |